POST Online Media Lite Edition


Agendia names Mark R. Straley as new CEO

Staff writer |
Irvine, Ca., USA - September 29, 2015, Irvine, Ca., USA - Agendia, Inc., a molecular cancer diagnostics company, announced the appointment of veteran diagnostics industry leader Mark R. Straley as chief executive officer.

Article continues below

Mr. Straley brings more than 25 years of international experience developing and commercializing clinical diagnostics and laboratory services. Most recently he served as President, Anatomical Pathology of Thermo Fisher Scientific (Waltham, Mass.).

Prior to this position he was President and CEO of Metamark Genetics (Cambridge, Mass.), a biotech company focusing on the development of prognostic and predictive diagnostic tests for personalized treatment of cancer patients.


What to read next

ImmunID appoints Bernhard Sixt as new CEO
WellCare Health Plans names Mark Leenay chief medical director
Core-Mark Holding appoints Scott McPherson as COO